advertisement
 |
|
Top Stories
Following passage by the House in July 2017, the Senate has voted to pass a reauthorization bill for FDA user-fee programs for drugs and medical devices ahead of the user-fee programs' expiration date.
/ read more /
FDA advances the progress of biosimilars with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.
/ read more / |
|
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
Take Our Survey!
How can we make Pharmaceutical Technology better? In our ongoing effort to provide the most timely, authoritative, and useful content about drug formulation, development, and manufacturing, we invite you to fill out this short survey. All responses are confidential and you may be eligible to win a $100 gift card!
Take the Survey |
|
|
|
advertisement
Renishaw, Inc
Material to follow
Learn more |
|
|
Industry News
The International Pharmaceutical Excipients Council (IPEC) has announced the winners of the 2017 award season.
/ read more /
On August 3, 2017, Bristol-Myers Squibb (BMS) announced that it has agreed to acquire biotech firm, IFM Therapeutics, in a deal worth over $1 billion to develop BMS' oncology pipeline
/ read more /
More Industry News
|
|
|
Supplier News
Charles River Labs has announced the acquisition of Brains On-Line (US), a contract research organization (CRO) that provides data on therapeutics for treating central nervous system (CNS) diseases.
/ read more /
Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.
/ read more /
More Supplier News
|
|
|
advertisement
PT Pharma Market Place
Material to follow
Learn more |
|
|
Bio/Pharma News
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline.
/ read more /
FDA has approved Mavyret (glecaprevir and pibrentasvir), a new molecular entity (NME), to treat chronic hepatitis C virus (HCV).
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The agency is asking for comments on a reflection paper on developing drugs for the needs of older patients.
/ read more /
Manufacturers are seeking greater oversight of how providers reimburse for and dispense covered drugs.
/ read more /
More Regulatory News
|
|
|
|
40th Anniversary
FDA's process validation process validation process validation guidance has evolved and the current lifecycle approach has profoundly influenced validation practice.
/ read more /
|
|
|
|
|
Facilities
Cheaper drugs are good for consumers, but cost restrictions limit drug company incentives to modernize facilities.
/ read more /
|
|
|
|
Outsourcing
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
/ read more /
|
|
|
Events
August 15–16, 2017
August 16–17, 2017
August 21–25, 2017
more events |
|
|
REFERENCE BOOKS |
 |
A compilation of informative, useful articles from Pharmaceutical Technology designed to help you meet the challenges of process analytical technology, be more efficient in testing, reduce over-processing, enhance consistency, and minimize rejects.
/ Click here /
More Reference Library |
|
|
|
eBOOKS
 |
New technologies, including single-use systems, are leading the push for faster production and higher titers. At the same time, ensuring quality in raw materials and water systems, and controlling contamination are paramount. In this Biologics and Sterile Manufacturing eBook, the editors explore key technology, process, and operational topics. |
|
|
|
|
|
